Incilius alvarius cell-based synthesis of 5-MeO-DMT

5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine) is the principal psychoactive component of the parotoid gland secretion of Incilius alvarius, where it comprises an estimated 20-30% of the dry weight of the secretion. The compound acts primarily at serotonin receptors, with higher affinity for 5-HT1A than 5-HT2A, and is metabolised by CYP2D6 to bufotenine. Interest in serotonergic psychedelics has risen because preclinical and clinical work suggests they promote neuroplasticity and may have therapeutic potential for mood and anxiety disorders; 5-MeO-DMT is described as pharmacodynamically distinct from other psychedelics due to its rapid onset, short duration and particular transcriptomic effects. This study was undertaken against a backdrop of ecological concern: demand for natural toad secretion for recreational, self-medication and spiritual use places Incilius alvarius under pressure. Lerer and colleagues set out to establish a cell line derived from Incilius alvarius parotoid gland tissue and to determine whether those cells could synthesise 5-MeO-DMT in vitro, providing a potential cruelty-free and sustainable source of naturally derived 5-MeO-DMT and associated parotoid compounds (so-called entourage molecules).

Parotoid gland tissue was obtained by partial gland biopsy from two anaesthetised Incilius alvarius toads following established anatomical descriptions and a modified version of a published full-thickness biopsy procedure. Glandular explants (~1 cm3) were rinsed with 70% isopropanol and phosphate-buffered saline and stored at ultra-low temperature until culture initiation; the procedure was reported to conform with best practices for handling laboratory animals. Cell isolation used enzymatic digestion with collagenase followed by an enzyme-free cell dissociation solution (ECDS). Dissociated material was strained through 0.40 μm and 0.22 μm filters and seeded into 24-well plates. Two surface treatments were compared: gelatin-coated wells and uncoated wells. Basal medium was adapted from a published recipe and comprised 2X L-15 medium with 10% fetal bovine serum and additional supplements (antibiotics, sugars, hormones, amino acids and ions). Cultures were incubated at 25°C with 5% CO2, with media changes every 3–4 days, and passaged on confluence. Cell immortalisation was performed using an SV40 T Antigen kit. Cultures were maintained for 45 days. For chemical analysis, culture media were filtered using an Amicon Ultra-0.5 centrifugal filter unit (10 kDa MWCO). 5-MeO-DMT quantification employed UPLC coupled to a Xevo TQ-S micro mass spectrometer. A calibration curve was prepared from a 5-MeO-DMT analytical standard in methanol over a concentration range of 1–2000 ng/mL. Monitored product/precursor ions included 130.25 m/z and 159.07 m/z. Media samples were analysed at two time points, 12 and 36 days after culture initiation, and compared to spontaneously secreted material collected from an Incilius alvarius toad.

Parotoid-derived cells were successfully isolated and immortalised, and cultures were sustained for 45 days. Dried material from the culture media had a light tan appearance similar to dried natural parotoid secretion. Media samples taken at 12 and 36 days were analysed and compared with spontaneously secreted toad material. LC-MS/MS analysis showed that the media samples produced by the cell cultures exhibited mass spectral fragmentation consistent with 5-MeO-DMT, matching the fragmentation pattern of the natural secreted material (the authors refer to a figure demonstrating this conformity). The chromatograms also contained additional peaks that the investigators did not identify; they report that the small amount of material limited further characterisation. The extracted text does not clearly report quantified concentrations or yields of 5-MeO-DMT from the cultures.

Lerer and colleagues interpret their findings as the first successful establishment of an Incilius alvarius parotoid cell line and as preliminary evidence that such cells can biosynthesise 5-MeO-DMT in vitro. They suggest that cell-based production could provide a scalable, cruelty-free source of naturally derived 5-MeO-DMT for research and potential clinical use while reducing ecological pressure on wild toad populations. The investigators emphasise the potential importance of additional indole alkylamines and other constituents present in parotoid secretions (for example bufothionine, serotonin, cinobufotenine, bufotenine and dehydrobufotenine), noting that these entourage molecules might synergistically modulate the effects of 5-MeO-DMT; however, they acknowledge that the interactions and mechanistic roles of such compounds remain unknown. The authors position their work as enabling further study of both 5-MeO-DMT and co-occurring secreted molecules. Key limitations are acknowledged: only small quantities were produced in this initial work, and with the detection methods used the team could not determine concentration or yield. Additional chromatographic peaks were observed but not identified because of limited material. The authors state that further research is required to optimise and scale the cell lines for upscaled production and to better characterise the full complement of secreted compounds and their biological effects.

This report presents preliminary evidence that an immortalised cell line derived from Incilius alvarius parotoid tissue can produce 5-MeO-DMT in vitro. Lerer and colleagues propose that cellular agriculture could offer a sustainable and cruelty-free alternative to harvesting toad secretions, and that the cell line may also permit investigation of other parotoid constituents (entourage molecules). The authors stress the need for optimisation to increase yield, more comprehensive chemical characterisation of additional peaks observed, and further work to clarify the biological roles and therapeutic potential of the secretion's components.